Skip to main content
SpringerLink
Log in

25 Years of p53 Research

  • Book
  • © 2005

Overview

Editors:
  1. Pierre Hainaut

    1. International Agency for Research on Cancer, World Health Organization, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Klas G. Wiman

    1. Cancer Center Karolinska, Karolinska Institute, Sweden

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • p53 is considered the most important cancer gene
  • p53 is a target for novel cancer therapy strategies already underway
  • p53 works as a sensor of oncogenic environmental stress
  • Written by world-leading scientists in the p53 field
  • Provides a unique summary of the field not available anywhere else

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Front Matter

    Pages i-xii
    Download chapter PDF

  2. The First Twenty-Five Years of p53 Research

    • Harlan Robins, Gabriela Alexe, Sandra Harris, A. J. Levine
    Pages 1-25

  3. Regulation of p53 DNA Binding

    • Kristine McKinney, Carol Prives
    Pages 27-51

  4. 20 Years of DNA Damage Signaling to p53

    • Kevin G. McLure, Michael B. Kastan
    Pages 53-71

  5. Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX

    • Geoffrey M. Wahl, Jayne M. Stommel, Kurt Krummel, Mark Wade
    Pages 73-113

  6. Regulation of the p53 Response by Cellular Growth and Survival Factors

    • Lauren Brown, Samuel Benchimol
    Pages 115-140

  7. P53, Cell Cycle Arrest and Apoptosis

    • Shulin Wang, Wafik S. El-Deiry
    Pages 141-163

  8. P53 Has a Direct Pro-apoptotic Action at the Mitochondria

    • Ute M. Moll
    Pages 165-181

  9. Manipulating the p53 Gene in the Mouse: Organismal Functions of a Prototype Tumor Suppressor

    • Lawrence A. Donehower, Dora Bocangel, Melissa Dumble, Guillermina Lozano
    Pages 183-207

  10. P53, P63, and P73: Internecine Relations?

    • Frank McKeon, Annie Yang
    Pages 209-222

  11. P73, P63 and Mutant P53: Members of Protein Complexs Floating in Cancer Cells

    • Olimpia Monti, Alexander Damalas, Sabrina Strano, Giovanni Blandino
    Pages 223-232

  12. P53: Gatekeeper, Caretaker or Both?

    • Carlos P. Rubbi, Jo Milner
    Pages 233-253

  13. Analysis of p53 Gene Alterations in Cancer: A Critical View

    • Thierry Soussi
    Pages 255-292

  14. Patterns of TP53 Mutations in Human Cancer: Interplay Between Mutagenesis, DNA Repair and Selection

    • Hong Shi, Florence Le Calvez, Magali Olivier, Pierre Hainaut
    Pages 293-319

  15. Prognostic and Predictive Value of TP53 Mutations in Human Cancer

    • Magali Olivier, Pierre Hainaut, Anne-Lise Børresen-Dale
    Pages 321-338

  16. P53 Links Tumor Development to Cancer Therapy

    • Michael T. Hemann, Scott W. Lowe
    Pages 339-351

  17. Novel p53-Based Therapies: Strategies and Future Prospects

    • Sonia Lain, David Lane
    Pages 353-376

  18. Wild Type p53 Conformation, Structural Consequences of p53 Mutations and Mechanisms of Mutant p53 Rescue

    • Andreas C. Joerger, Assaf Friedler, Alan R. Fersht
    Pages 377-397

  19. Mutant p53 Reactivation as a Novel Strategy for Cancer Therapy

    • Galina Selivanova, Vladimir J. N. Bykov, Klas G. Wiman
    Pages 399-419

  20. Novel Approaches to p53-Based Therapy: ONYX-015

    • Frank McCormick
    Pages 421-429
Back to top

Keywords

About this book

1. Communication, awareness and access to information: Given the complexity of the field and the fact that data pertaining to each particular aspects of p53 biology or deregulation are scattered in many different publications, it is extremely difficult to access the full scale of relevant information of any specific p53-related topic. Review arcticles, despite their fundamental role in disseminating knowledge, usually focus only on general mechanisms and do not discuss in detail the many variations that can occur with respect to cell type, particular mutation type, as well as biological activation context. Books such as this one may help in this task by putting into perspective both general considerations on the p53 pathway and more specific information on various aspects of p53. In the longer term, however, open access to p53 complexity will require the development of knowledge bases accessible through the web and using simple navigation tools to guide users towards the specific information they need. Several efforts are currently being developed in that direction. They need to be strenghtened and better integrated within the rapidly growing galaxy of web-based information sources on molecular and individual variations in cancer. 2. Reference functional assays and structural analysis: Given the huge diversity of cellular and animal models for wild-type or mutant p53 functions, it will be important to set up standard, universally accepted assays to measure critical p53 protein functions.

Editors and Affiliations

  • International Agency for Research on Cancer, World Health Organization, France

    Pierre Hainaut

  • Cancer Center Karolinska, Karolinska Institute, Sweden

    Klas G. Wiman

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation